Lawmakers Seek FDA Review Changes, REMS Assessment in PDUFA Reauthorization

Despite more than a year of negotiations between industry and the FDA on reauthorization of the Prescription Drug User Fee Act (PDFUA V), lawmakers are pushing for additional changes to revamp the approval process — a move that could threaten a swift reauthorization.
Drug Industry Daily